肿瘤基因治疗_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

夏仁品 , 综述 , 严律南 , 审校

Corresponding author：

Keywords：

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 夏仁品,综述,严律南,审校. 肿瘤基因治疗. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 1998, 5(2): 126-127. doi: Copy

1.	Rosenberg SA, Power LB, Noonan KE, et al. . Gene transfer into human immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retrovival gene transduction. N Engl J Med, 1990; 323∶570.
2.	Anderson C. Gene therapy research under fire over controv ersial cancer trail. Nature, 1992; 360∶399.
3.	Rosenberg SA, Puyal C, Felgner PL, et al. The immunotherapy and gene therapy of cancer. J Clin Oncol, 1992; 10∶180.
4.	Hwu P, Yannelli J, Kriegler M, et al. Function and molecular characterization of tumor infiltrating lymphocytes transfected with tumor necrosis factoralpha cDNA for the gene therapy of cancer in human. J Immunol, 1993; 150(9)∶4104.
5.	Thara H, Sandgren EP, Quaife CJ, et al. Antitumor effects of interleukin 12 (IL12)： application for he immunotherapy and gene therapy of cancer. Ther Gene, 1995; 2(2)∶96.
6.	Miller AR, Peters WT, Posner M, et al. Cytokine mediated gene therapy for cancer. Ann Surg Qncol, 1994; 1(5)∶436.
7.	Sobol RE, Dinman JD, Icho T, et al. Interleukin2 gene therapy in a patient with glioblastoma. Gene Ther, 1995; 2(2)∶164.
8.	Chen L, Thomas EK, Hus L, et al. Human papilloma virus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Aad Sci USA, 1991; 88∶110.
9.	Corey CA, Desilva CA, Williams DA, et al. Serial transplantation of methothrexate resistance bone marrow protection of murine recipients from drug toxicity by progency of transfected stem cells. Blood, 1990; 75∶337.
10.	Keith WN, Brown R, Prognell IB, et al. Retrovirus mediated transfer and expression of GMCSF in haematopoietic cells. Br J Cancer, 1990; 62∶388.
11.	Leone A, Jr Cakaet, Mareel M, et al. Reduced tumor incidence of metastatic potential and cytokine responsiveness of nm23 transfected melanoma cells. Cell, 1991; 65∶25.
12.	Liu TJ, Zhang WW, Taylor DL, et al. Growth suppression of human head and neck cancer cells by the introduction of a wildtype p53 gene via a recombinant adenovirus. Cancer Res, 1994; 54(14)∶3662.
13.	Mereer WE, Shielps MT, Lin D, et al. Growth suppression induced by wild type p53 protein is accompanied by selective downregulation of proliferatioin cell nuclear antigen expression. Proc Natl Acad Sci USA, 1991; 88∶1958.
14.	Huang HJS, Golden JW, Wiest D, et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science, 1988; 242∶1563.

1. Rosenberg SA, Power LB, Noonan KE, et al. . Gene transfer into human immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retrovival gene transduction. N Engl J Med, 1990; 323∶570.
2. Anderson C. Gene therapy research under fire over controv ersial cancer trail. Nature, 1992; 360∶399.
3. Rosenberg SA, Puyal C, Felgner PL, et al. The immunotherapy and gene therapy of cancer. J Clin Oncol, 1992; 10∶180.
4. Hwu P, Yannelli J, Kriegler M, et al. Function and molecular characterization of tumor infiltrating lymphocytes transfected with tumor necrosis factoralpha cDNA for the gene therapy of cancer in human. J Immunol, 1993; 150(9)∶4104.
5. Thara H, Sandgren EP, Quaife CJ, et al. Antitumor effects of interleukin 12 (IL12)： application for he immunotherapy and gene therapy of cancer. Ther Gene, 1995; 2(2)∶96.
6. Miller AR, Peters WT, Posner M, et al. Cytokine mediated gene therapy for cancer. Ann Surg Qncol, 1994; 1(5)∶436.
7. Sobol RE, Dinman JD, Icho T, et al. Interleukin2 gene therapy in a patient with glioblastoma. Gene Ther, 1995; 2(2)∶164.
8. Chen L, Thomas EK, Hus L, et al. Human papilloma virus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Aad Sci USA, 1991; 88∶110.
9. Corey CA, Desilva CA, Williams DA, et al. Serial transplantation of methothrexate resistance bone marrow protection of murine recipients from drug toxicity by progency of transfected stem cells. Blood, 1990; 75∶337.
10. Keith WN, Brown R, Prognell IB, et al. Retrovirus mediated transfer and expression of GMCSF in haematopoietic cells. Br J Cancer, 1990; 62∶388.
11. Leone A, Jr Cakaet, Mareel M, et al. Reduced tumor incidence of metastatic potential and cytokine responsiveness of nm23 transfected melanoma cells. Cell, 1991; 65∶25.
12. Liu TJ, Zhang WW, Taylor DL, et al. Growth suppression of human head and neck cancer cells by the introduction of a wildtype p53 gene via a recombinant adenovirus. Cancer Res, 1994; 54(14)∶3662.
13. Mereer WE, Shielps MT, Lin D, et al. Growth suppression induced by wild type p53 protein is accompanied by selective downregulation of proliferatioin cell nuclear antigen expression. Proc Natl Acad Sci USA, 1991; 88∶1958.
14. Huang HJS, Golden JW, Wiest D, et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science, 1988; 242∶1563.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

肿瘤基因治疗

Abstract Full text Figures/Tables Video References Cited by

Format

Content